Guerrero-Molina A, Cruz-Álvarez M, Tenopala-Villegas S

Language: Spanish
References: 23
Page: 290-295
PDF size: 159.92 Kb.

ABSTRACT

Platelet-rich plasma (PRP) is an autologous blood product containing growth factors and proteins, widely employed in the clinical setting for tissue repair. Robust evidence in basic science literature has facilitated clinical research involving PRP for patients with disc disease and lumbar pain. Degenerative disc disease (DDD) has been identified as a significant contributor to lower back pain, with approximately 40% of patients under 30 and 90% of those over 50 experiencing lumbar pain showing MRI findings consistent with degenerative changes in intervertebral discs. Regenerative medicine within the disc has primarily been studied in patients with chronic, untreatable lumbar pain. Objective: to understand the available evidence regarding the efficacy of PRP in lumbar disc herniation. By understanding the scientific evidence supporting PRP as a lumbar disc herniation treatment, a research project can be developed, providing the theoretical foundation for implementing this therapy in the Mexican population. A search was conducted using PUBMED, ClinicalKey (Elsevier), Medscape, Science Direct, and Google Scholar databases. Conclusions: despite promising results in several studies on intradiscal PRP injection, small sample sizes and non-standardized graft preparation procedures have hindered these research efforts.

REFERENCES

1. Kirnaz S, Singh S, Capadona C, Lintz M, Goldberg JL, McGrath LB Jr, et al. Innovative biological treatment methods for degenerative disc disease. World Neurosurg. 2022; 157: 282-99.

2. Navani A, Hames A. Platelet-rich plasma injections for lumbar discogenic pain: a preliminary assessment of structural and functional changes. Tech Reg Anesth Pain Manag. 2015; 19(1): 38-44.

3. Romaniyanto, Mahyudin F, Sigit Prakoeswa CR, Notobroto HB, Tinduh D, Ausrin R, et al. An update of current therapeutic approach for Intervertebral Disc Degeneration: A review article. Ann Med Surg (Lond). 2022; 77: 103619.

4. Wu PI, Meleger A, Witkower A, Mondale T, Borg-Stein J. Nonpharmacologic options for treating acute and chronic pain. PM R. 2015; 7(11 Suppl): S278-94.

5. Singh G, Hsu WK. Biologics of lumbar interbody fusion. Semin Spine Surg. 2018; 30(4): 194-202.

6. Parizel P. Grainger & Allison's diagnostic radiology. Poland: Elsevier; 2021.

7. Mascarinas A, Harrison J, Boachie-Adjei K, Lutz G. Regenerative treatments for spinal conditions. Phys Med Rehabil Clin N Am. 2016; 27(4): 1003-17.

8. Bakshi N. Terapias biológicas en cirugía ortopédica. España: Elsevier; 2020.

9. Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Plasma rico en plaquetas: ¿mito o realidad? Radiología. 2018; 60(6): 465-75.

10. Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop. 2016; 40(6): 1321-8.

11. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, et al. Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R. 2016; 8(1): 1-10; quiz 10.

12. Cheng J, Santiago KA, Nguyen JT, Solomon JL, Lutz GE. Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5-9 years. Regen Med. 2019; 14(9): 831-840. doi: 10.2217/rme-2019-0040.

13. Navani A, Manchikanti L, Albers SL, Latchaw RE, Sanapati J, Kaye AD, et al. Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2019; 22(1S): S1-74.

14. Jain D, Goyal T, Verma N, Paswan AK, Dubey RK. Intradiscal platelet-rich plasma injection for discogenic low back pain and correlation with platelet concentration: a prospective clinical trial. Pain Med. 2020; 21(11): 2719-25.

15. Desai MJ, Mansfield JT, Robinson DM, Miller BC, Borg-Stein J. Regenerative medicine for axial and radicular spine-related pain: a narrative review. Pain Pract. 2020; 20(4): 437-53.

16. Fiani B, Dahan A, El-Farra MH, Kortz MW, Runnels JM, Suliman Y, et al. Cellular transplantation and platelet-rich plasma injections for discogenic pain: a contemporary review. Regen Med. 2021; 16(2): 161-74.

17. Chang MC, Park D. The effect of intradiscal platelet-rich plasma injection for management of discogenic lower back pain: a meta-analysis. J Pain Res. 2021; 14: 505-12.

18. Lutz C, Cheng J, Prysak M, Zukofsky T, Rothman R, Lutz G. Clinical outcomes following intradiscal injections of higher-concentration platelet-rich plasma in patients with chronic lumbar discogenic pain. Int Orthop. 2022; 46(6): 1381-5.

19. Schneider BJ, Hunt C, Conger A, Qu W, Maus TP, Vorobeychik Y, et al. The effectiveness of intradiscal biologic treatments for discogenic low back pain: a systematic review. Spine J. 2022; 22(2): 226-37.

20. Jiang Y, Zuo R, Yuan S, Li J, Liu C, Zhang J, et al. Transforaminal endoscopic lumbar discectomy with versus without platelet-rich plasma injection for lumbar disc herniation: a prospective cohort study. Pain Res Manag. 2022; 2022: 6181478.

21. Akeda K, Takegami N, Yamada J, Fujiwara T, Ohishi K, Tamaru S, et al. Platelet-rich plasma-releasate (PRPr) for the treatment of discogenic low back pain patients: long-term follow-up survey. Medicina (Kaunas). 2022; 58(3): 428.

22. Zielinski MA, Evans NE, Bae H, Kamrava E, Calodney A, Remley K, et al. Safety and efficacy of platelet rich plasma for treatment of lumbar discogenic pain: a prospective, multicenter, randomized, double-blind study. Pain Physician. 2022; 25(1): 29-34.

23. Zhang J, Liu D, Gong Q, Chen J, Wan L. Intradiscal autologous platelet-rich plasma injection for discogenic low back pain: a clinical trial. Biomed Res Int. 2022; 2022: 9563693.

EVIDENCE LEVEL

V